Literature DB >> 21402761

Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model.

Carla Calderon Toledo1, Ida Arvidsson, Diana Karpman.   

Abstract

Enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic E. coli (EHEC) are related attaching and effacing (A/E) pathogens. The genes responsible for the A/E pathology are carried on a chromosomal pathogenicity island termed the locus of enterocyte effacement (LEE). Both pathogens share a high degree of homology in the LEE and additional O islands. EHEC prevalence is much lower in areas where EPEC is endemic. This may be due to the development of antibodies against common EPEC and EHEC antigens. This study investigated the hypothesis that EPEC infections may protect against EHEC infections. We used a mouse model to inoculate BALB/c mice intragastrically, first with EPEC and then with EHEC (E. coli O157:H7). Four control groups received either a nonpathogenic E. coli (NPEC) strain followed by EHEC (NPEC/EHEC), phosphate-buffered saline (PBS) followed by EHEC (PBS/EHEC), EPEC/PBS, or PBS/PBS. Mice were monitored for weight loss and symptoms. EPEC colonized the intestine after challenge, and mice developed serum antibodies to intimin and E. coli secreted protein B (encoded in the LEE). Prechallenge with an EPEC strain had a protective effect after EHEC infection, as only a few mice developed mild symptoms, from which they recovered. These mice had an increase in body weight similar to that in control animals, and tissue morphology exhibited mild intestinal changes and normal renal histology. All mice that were not prechallenged with the EPEC strain developed mild to severe symptoms after EHEC infection, with weight loss as well as intestinal and renal histopathological changes. These data suggest that EPEC may protect against EHEC infection in this mouse model.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21402761      PMCID: PMC3125830          DOI: 10.1128/IAI.01024-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells.

Authors:  B Kenny; R DeVinney; M Stein; D J Reinscheid; E A Frey; B B Finlay
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

2.  Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge.

Authors:  M S Donnenberg; C O Tacket; G Losonsky; G Frankel; J P Nataro; G Dougan; M M Levine
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

3.  A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells.

Authors:  S Knutton; I Rosenshine; M J Pallen; I Nisan; B C Neves; C Bain; C Wolff; G Dougan; G Frankel
Journal:  EMBO J       Date:  1998-04-15       Impact factor: 11.598

4.  The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69.

Authors:  S J Elliott; L A Wainwright; T K McDaniel; K G Jarvis; Y K Deng; L C Lai; B P McNamara; M S Donnenberg; J B Kaper
Journal:  Mol Microbiol       Date:  1998-04       Impact factor: 3.501

5.  Genotypic and phenotypic changes in the emergence of Escherichia coli O157:H7.

Authors:  P Feng; K A Lampel; H Karch; T S Whittam
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

Review 6.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  Human colostrum contains IgA antibodies reactive to enteropathogenic Escherichia coli virulence-associated proteins: intimin, BfpA, EspA, and EspB.

Authors:  I Loureiro; G Frankel; J Adu-Bobie; G Dougan; L R Trabulsi; M M Carneiro-Sampaio
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-08       Impact factor: 2.839

8.  Inhibition of enteropathogenic Escherichia coli (EPEC) adhesion to HeLa cells by human colostrum: detection of specific sIgA related to EPEC outer-membrane proteins.

Authors:  L M Camara; S B Carbonare; M L Silva; M M Carneiro-Sampaio
Journal:  Int Arch Allergy Immunol       Date:  1994       Impact factor: 2.749

9.  Molecular evolution of a pathogenicity island from enterohemorrhagic Escherichia coli O157:H7.

Authors:  N T Perna; G F Mayhew; G Pósfai; S Elliott; M S Donnenberg; J B Kaper; F R Blattner
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

10.  Enteropathogenicity markers in Escherichia coli isolated from infants with acute diarrhoea and healthy controls in Rio de Janeiro, Brazil.

Authors:  A C Rosa; A T Mariano; A M Pereira; A Tibana; T A Gomes; J R Andrade
Journal:  J Med Microbiol       Date:  1998-09       Impact factor: 2.472

View more
  13 in total

Review 1.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.

Authors:  Miguel O'Ryan; Roberto Vidal; Felipe del Canto; Juan Carlos Salazar; David Montero
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Prolonged NF-κB activation by a macrophage inhibitory cytokine 1-linked signal in enteropathogenic Escherichia coli-infected epithelial cells.

Authors:  Hye Jin Choi; Juil Kim; Kee Hun Do; Seong-Hwan Park; Yuseok Moon
Journal:  Infect Immun       Date:  2013-02-12       Impact factor: 3.441

3.  Oral Administration with Live Attenuated Citrobacter rodentium Protects Immunocompromised Mice from Lethal Infection.

Authors:  Shuyu Wang; Xue Xia; Yue Liu; Fengyi Wan
Journal:  Infect Immun       Date:  2022-07-05       Impact factor: 3.609

Review 4.  Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection.

Authors:  Victor A Garcia-Angulo; Anjana Kalita; Alfredo G Torres
Journal:  Vaccine       Date:  2013-05-22       Impact factor: 3.641

Review 5.  Clinical implications of enteroadherent Escherichia coli.

Authors:  Margarita M P Arenas-Hernández; Ygnacio Martínez-Laguna; Alfredo G Torres
Journal:  Curr Gastroenterol Rep       Date:  2012-10

6.  A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles.

Authors:  Anne-lie Ståhl; Ida Arvidsson; Karl E Johansson; Milan Chromek; Johan Rebetz; Sebastian Loos; Ann-Charlotte Kristoffersson; Zivile D Békássy; Matthias Mörgelin; Diana Karpman
Journal:  PLoS Pathog       Date:  2015-02-26       Impact factor: 6.823

7.  Shiga toxin signals via ATP and its effect is blocked by purinergic receptor antagonism.

Authors:  Karl E Johansson; Anne-Lie Ståhl; Ida Arvidsson; Sebastian Loos; Ashmita Tontanahal; Johan Rebetz; Milan Chromek; Ann-Charlotte Kristoffersson; Ludger Johannes; Diana Karpman
Journal:  Sci Rep       Date:  2019-10-07       Impact factor: 4.379

Review 8.  Treatment Strategies for Infections With Shiga Toxin-Producing Escherichia coli.

Authors:  Sabrina Mühlen; Petra Dersch
Journal:  Front Cell Infect Microbiol       Date:  2020-05-06       Impact factor: 5.293

9.  Annexin Induces Cellular Uptake of Extracellular Vesicles and Delays Disease in Escherichia coli O157:H7 Infection.

Authors:  Ashmita Tontanahal; Ida Arvidsson; Diana Karpman
Journal:  Microorganisms       Date:  2021-05-26

Review 10.  Intestinal Pathogenic Escherichia coli: Insights for Vaccine Development.

Authors:  Maricarmen Rojas-Lopez; Ricardo Monterio; Mariagrazia Pizza; Mickaël Desvaux; Roberto Rosini
Journal:  Front Microbiol       Date:  2018-03-20       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.